FEATURE ARTICLES
Not only is investment increasing in pharma, but innovation is propelling growth in multiple drug segments, and the people supporting this growth and innovation remain happy.
- M&A In GLP-1 Technology: Practical Recommendations And Best Practices
- Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- ISPE Awards 8 Innovative Pharma Facilities
- The Transition To E-Labeling Is More Than Uploading PDFs
- Are You Still Evaluating CMOs When You Really Need A CDMO?
- Program Manager Alignment And Integration: Best Practices When Working With A CDMO
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-2179880251-digital-validation-hands-blue]( "The Evolution Of EAM/CMMS In Pharma Manufacturing")
The Evolution Of EAM/CMMS In Pharma ManufacturingExplore pharma’s shift from paper-based maintenance to modern EAM/CMMS that shows how digital tools boost compliance, reduce downtime, and improve data accuracy and productivity.
-
State Of Validation Report 202412/17/2024
Explore trends in compliance, audit readiness, digital systems, process efficiencies, emerging KPIs, and the adoption of Pharma 4.0 technologies.
-
Enabling CDMOs To Focus On Core Priorities4/26/2024
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
Achieve Higher Targeted Concentrations9/30/2025
Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production.
-
Leveraging Life Sciences Data For Intelligent Decision-Making2/18/2025
Industry 4.0 drives life sciences to prioritize data-driven decision-making by integrating advanced technologies in QMS. Discover how modern data management can improve compliance.
-
Epigenetics Application Guide: RNA Modifications9/26/2024
Learn about the rapidly evolving field of RNA modifications, including innovative techniques like miCLIP and RIP for mapping chemical modifications and understanding RNA’s role in cellular processes.
PHARMA ONLINE APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
- 11.13.25 -- Eco-Friendly HBL: Cheaper, Cleaner, And Ready For Pharma
- 11.13.25 -- STREAM Edition: Addressing The Business Side Of GLP-1 Manufacturing
- 11.12.25 -- Redefining API Manufacturing Through Continuous Innovation
- 11.12.25 -- Oligo Scale-Up Just Got Easier – Here's How
- 11.11.25 -- Better Delivery, Better Outcomes: Simplifying Dosing With Nanoforming
INDUSTRY NEWS
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
![Dollar Icon from Medical pills-GettyImages-1708867150]( "Oregon Court Upholds Drug Price Transparency Law")
Oregon Court Upholds Drug Price Transparency LawThe law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Novartis Expands U.S. footprint With New Radioligand Therapy Facility In California11/12/2025
Novartis, a leading global innovative medicines company, today announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. This state-of-the-art site represents a key milestone in the company’s previously announced $23 billion investment in US infrastructure over the next five years.
-
AES Cleanroom Technology Establishes New Office In Research Triangle Park To Support Regional Drug Manufacturing Growth11/11/2025
AES Cleanroom Technology, an award-winning leader in modular cleanroom design and construction, has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.
-
Federal Equipment Announces Diagnostics Laboratory Equipment Auction11/10/2025
Federal Equipment held in conjunction with Proxio Group announces diagnostics laboratory equipment auction.
-
CDMO Codis Launches As Commercial Spray Drying And Amorphous Solid Dispersions Provider10/31/2025
Codis officially launches as a new global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. Formed through the integration of Particle Dynamics in the US and the Haverhill, UK spray drying facility previously operated by EUROAPI, Codis combines decades of regulatory expertise and manufacturing strength under one brand.
